dienogest has been researched along with Leiomyoma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sasagawa, T; Takagi, H; Takakura, M | 1 |
| Lumbiganon, P; Pattanittum, P; Sangkomkamhang, US | 1 |
| Ban Frangež, H; Giacobbe, V; Granese, R; Ietto, C; Laganà, AS; Palmara, VI; Triolo, O; Vrtačnik-Bokal, E | 1 |
| Ichigo, S; Imai, A; Matsunami, K; Suzuki, N; Takagi, H | 1 |
1 review(s) available for dienogest and Leiomyoma
| Article | Year |
|---|---|
Progestogens or progestogen-releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy).
Topics: Adult; Antineoplastic Agents, Hormonal; Bias; Contraceptives, Oral; Desogestrel; Female; Goserelin; Humans; Intrauterine Devices, Medicated; Leiomyoma; Leuprolide; Levonorgestrel; Lynestrenol; Medroxyprogesterone Acetate; Menstruation; Middle Aged; Nandrolone; Norethindrone Acetate; Premenopause; Progestins; Randomized Controlled Trials as Topic; Tumor Burden; Uterine Neoplasms | 2020 |
1 trial(s) available for dienogest and Leiomyoma
| Article | Year |
|---|---|
Dienogest as preoperative treatment of submucous myomas for hysteroscopic surgery: a prospective, randomized study.
Topics: Adult; Danazol; Female; Hormone Antagonists; Humans; Hysteroscopy; Leiomyoma; Nandrolone; Preoperative Care; Preoperative Period; Prospective Studies; Treatment Outcome; Uterine Neoplasms | 2016 |
2 other study(ies) available for dienogest and Leiomyoma
| Article | Year |
|---|---|
Risk factors of heavy uterine bleeding in patients with endometriosis and adenomyosis treated with dienogest.
Topics: Adenomyosis; Adult; Endometriosis; Female; Humans; Leiomyoma; Quality of Life; Retrospective Studies; Risk Factors; Uterine Hemorrhage | 2023 |
Beneficial effects of dienogest on uterine myoma volume: a retrospective controlled study comparing with gonadotropin-releasing hormone agonist.
Topics: Adult; Antineoplastic Agents, Hormonal; Case-Control Studies; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Leiomyoma; Leuprolide; Middle Aged; Nandrolone; Premenopause; Retrospective Studies; Tumor Burden; Uterine Neoplasms | 2011 |